Efthalia Angelopoulou

Author

National and Kapodistrian University of Athens ORCID

Also Known As

Angelopoulou, Efthalia, E. Angelopoulou, Efthalia Angelopoulou

125

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Eginition Hospital University General Hospital Attikon Philipps University of Marburg Hygeia Hospital

About

Efthalia Angelopoulou is an author at National and Kapodistrian University of Athens specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	124
2	Public Health	4	4	70
3	Health Sciences	1	1	16
4	Nursing	1	1	11
5	Allergy	1	1	17

Efthalia Angelopoulou

Publications

341

Citations

H-Index

Page 1

	Year	Citations
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders Yam Nath Paudel, Efthalia Angelopoulou, Bridgette D. Semple, ACS Chemical Neuroscience	2020	98
Factor XIIIa+ dendritic cells and S‐100 protein+ Langerhans' cells in adult periodontitis Xanthippi Dereka, Konstantinos I. Tosios, Evanthia Chrysomali, Journal of Periodontal Research	2004	29
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease Efthalia Angelopoulou, Maria Bozi, Athina‐Maria Simitsi, Parkinsonism & Related Disorders Neurodegenerative DiseasesParkinson DiseaseEnvironmental HealthEnvironmental FactorsDifferent Parkinson	2019	23
Phenotypic Characteristics in GBA-Associated Parkinson’s Disease: A Study in a Greek Population Athina Maria Simitsi, Christos Koros, Marina Moraitou, Journal of Parkinson s Disease	2018	19
REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers Athina Maria Simitsi, Christos Koros, María Stamelou, SLEEP	2020	19
Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study Christos Koros, Athina‐Maria Simitsi, Nikolaos Papagiannakis, Parkinsonism & Related Disorders	2021	19
Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia Vasiliki Georgakopoulou, Aikaterini Gkoufa, Aristeidis Tsakanikas, Experimental and Therapeutic Medicine Geriatric PsychiatryFull VaccinationAgingElderly PatientsCovid-19 Epidemiology	2023	19
Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study Christos Koros, Athina‐Maria Simitsi, Nikolaos Papagiannakis, Journal of Parkinson s Disease	2023	18
Unraveling the Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Myasthenia Gravis Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi ACS Chemical Neuroscience Mg PathogenesisGlycobiologyImmunologyAutoantibodiesNeuroimmunology	2020	17
Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease Efthalia Angelopoulou, Maria Bozi, Athina‐Maria Simitsi, Journal of the Neurological Sciences Neurological DisorderParkinson DiseaseDementiaClinical NeurologyDiagnosis	2022	17

Page 1